Navigation Links
C. therm. Polymerase One-Step RT-PCR System

ers
  • Sample: 50 pg to 5 g total RNA.
  • Temperature optimum, reverse transcriptase reaction: 5072C.
  • Divalent ion requirement: Mg2+.
  • Works with UNG (RT-PCR carry-over prevention).
  • Accepts DIG-labeled and other modified nucleotides.
Experimental result Comparison of C. therm Polymerase, Supplier Ls RNase H - Reverse Transcriptase, and Supplier Ps AMV Reverse Transcriptase for RT-PCR. Template: Total RNA isolated from K562 cell line. Primer: TGF-beta. Target: 650 bp product. 1.5 M betaine to dissolve secondary structure. Positive Controls: 1 ng of a 997 bp beta-actin fragment from mouse. Lane 1: C. therm. polymerase/Taq for 30 min at 60C. Lane 2: Superscript II/Taq for 50 min at 42C. Lane 3: AMV(Promega)/Taq for 60 min at 42C. Result: C. therm works on templates where other systems fail. Key advantages
  • Extends the sensitivity of RT-PCR, because the system can detect as few as 100 copies of a template (e.g. viral RNA).
  • Ensures high specificity amplification, because the system will accurately amplify target RNA even in the presence of large amounts of non-specific RNA.
  • Efficiently transcribes GC-rich RNA regions, due to the high temperature of the cDNA reaction and the presence of DMSO in the reaction buffer.
  • Ensures high fidelity RT-PCR, because the C. therm. Polymerase One-Step RT-PCR System has a twofold lower transcriptional error rate than Tth DNA Polymerase.

  • '"/>


Source:


Page: All 1 2 3

Related biology technology :

1. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
2. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
3. Pfu DNA Polymerase as a Hot Start Alternative
4. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
5. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
6. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
7. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
8. High-Fidelity PCR with a Novel Polymerase Mixture
9. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
10. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
11. The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated DNA

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: therm Polymerase One Step PCR System

(Date:11/24/2009)... Health care employment grew by 29...ly one to show consistent growth during the U.S. r... remain in trouble, and health systems are coming ..., instead of just administrators. , ...e employment continued growing in October despite ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- S...amp; Drug Administration (SFDA) has approved the,i...oral insulin project,(Nodlin), an innovative insul...l allows Biolaxy to initiate its first phase I cli...racteristic of high blood glucose and poor,metabol...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNews...), formerly Calotto Capital Inc., a leading provid...he stem cell research and fertility clinic markets... for the third quarter ended September 30, 2009. ,...46 million compared with $1.43 million in Q3 2008,...
(Date:11/24/2009)..., BOZEN, Italy, November 24 ... a new Canadian joint venture with a group of sele... company will operate under the,name Health Roboti...ort,Health Robotics, i.v. Room of the Future conce...ings i.v.STATION(TM), i.v.SOFT(TM), and OMM(TM).,H...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...12 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) to...e 3 clinical programs, Unit Dose Budesonide (UDB) ... treatment of migraine. For UDB, all,patients hav...itial Phase 3,clinical trial, and for MAP0004, the...in its initial Phase 3 clinical trial by the end o...
...of Schedule , , ST. LOUIS and RICHMOND, Calif., ... ) today announced it has reached a major producti...h Sigma-Aldrich Corporation (Nasdaq: SIAL ) to c...for research applications. The milestone triggers ...ng this production milestone more than one year ah...
...sset, Inc. (Nasdaq: VRUS ) announced today that ...reed with the FDA on the final design for a phase ...atitis C (HCV), slated to initiate in the first qu...8 is advancing into a large phase 2b trial," state...ical Officer. "R7128 is the most advanced nucleosi...
Other Biology Technology:MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs 2MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs 3Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement 2Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement 3Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5
(Date:11/25/2009)...tate University assistant professors recently rece...(NSF) to continue research beneficial to understan...000. , Christopher Blackwood, assistant professo...arded grants to support two separate research proj...tter Decomposer Communities and Functions from the...
(Date:11/24/2009)...ence is opening new doors to understanding how sou...aring of a marine mammal or if they hear it at al...ay scanners that NASA uses to detect flaws in the ... allowing scientists to peek inside the giant head...e-dimensional replicas of a whale,s hearing anatom...
(Date:11/24/2009)...nd the American College of Medical Toxicology (ACM...publication of the Journal of Medical Toxicology ...g in March 2010. It was previously published by t...rnal of Medical Toxicology , an international, pee...science and practice of medical toxicology. The q...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Strep B Seems to Trick Immune System 51448 1Bathtub Accidents Injure 43 000 U S Kids Each Year 51446 1Bathtub Accidents Injure 43 000 U S Kids Each Year 51446 2National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio August 31 September 1 51444 1National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio August 31 September 1 51444 2
...ered that two microRNA (miRNA) molecules help cont...of B-cell chronic lymphocytic leukemia (B-CLL), th...r findings, published in the December 15 issue of ...ing as powerful regulators of gene expression in c... drug treatment, the investigators say. , In t...
...blem could be eliminated simply by dusting slag on...& Industry, the magazine of the SCI. , In the ...f damage annually. , Researcher David Cowen and...t applying slag to wheat growing in greenhouses ha...orporate the silica and express it as spiky struct...
... of plants to defend themselves by accumulating hi...me insects, and that such adaptation potentially e...ites may in turn evolve to deal with high levels o...zabeth Pilon-Smits of Colorado State University an...rnia, Berkeley, appear in the November 21st issue ...
Other Biology News:Pair of microRNA molecules controls major oncogene in most common leukemia 2New moth variety disarms plants guarded by selenium 2
DNeasy Plant Mini Kit (250) from QIAGEN
...d Rocker, with 12" x 14" table; 115V 512500-00 VSR...20V. The VSR-50 Variable Speed Rocker is an essen...ovides a rhythmic side-to-side motion and its vari...nt. This makes it ideal for: gel staining/destaini...
Benzonase Nuclease HC, Purity > 90% from Novagen
... Plate is a 96-well ELISA-compatible plate (contai...r Monoclonal Antibody is immobilized by a method t... specifically recognizes the tail fiber protein of... a capacity of 10 9 phage per well and low non-sp...
Biology Products: